more_reports

Streetwise Articles



Explorer's Drilling Merges Three Zones into One at Red Lake Project in Canada
Source: Streetwise Reports  (10/1/19)
This is because the trio shares similar and correlatable geology and/or mineralization styles. More >


Bob Moriarty

Maple Gold for $3.02 an Ounce US
Source: Bob Moriarty for Streetwise Reports  (10/1/19)
Bob Moriarty of 321 Gold explains why he has been buying shares of this gold explorer with a project in Quebec. More >


Deflation or Inflation: Gold Doesn't Care
Source: Rudi Fronk and Jim Anthony for Streetwise Reports  (10/1/19)
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price. More >


Phase 2 Data from Potential Multibagger Biopharma 'Checks All the Boxes'
Source: Streetwise Reports  (9/30/19)
The latest clinical trial results are dissected in a ROTH Capital Partners report. More >


Energy Storage Firm Signs Three New Supply, Distribution Agreements Worth $12.6 Million
Source: Streetwise Reports  (9/30/19)
These agreements come after Mercedes-Benz ended its arrangement with the small-cap. More >


U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer
Source: Streetwise Reports  (9/30/19)
The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. More >


Adrian Day

Cheap for a Reason: Osisko Gold Royalties and Fortuna
Source: Adrian Day for Streetwise Reports  (9/30/19)
Money manager Adrian Day reviews two undervalued resource companies that have seen important recent developments. More >


Oil & Gas Explorer Closes Asset Sale, Receives First Milestone Payment
Source: Streetwise Reports  (9/30/19)
The transaction yielded for the company $30 million in cash, a production royalty and event-specific revenue. More >


Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer
Source: Streetwise Reports  (9/30/19)
Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. More >


Golden Arrow Resources Completes Selling of 25% Interest in Puna Operations to SSR Mining; Exciting Exploration Up Next
Source: The Critical Investor for Streetwise Reports  (9/30/19)
The Critical Investor reviews Golden Arrow's deal with SSR Mining to sell its remaining interest, and also discusses the company's other projects. More >


Production Test Successful at Well in Argentina's Vaca Muerta
Source: Streetwise Reports  (9/30/19)
The result reportedly shows the potential of the formation within a specific block. More >


Michael Ballanger

My Second-Worst Nightmare
Source: Michael Ballanger for Streetwise Reports  (9/30/19)
Sector expert Michael Ballanger interprets the implications of the last COT report for the precious metals markets. More >


Miner Increases Gold Ounces, Grade in New Resource Estimate
Source: Streetwise Reports  (9/29/19)
Company notes "significant increases in gold grade and ounces of gold." More >


Firm Expands Footprint of Gold Target at Idaho Project
Source: Streetwise Reports  (9/29/19)
Next for the Canadian company and its asset is updating the mineral resource estimate. More >


Canadian Energy Company Makes 'New Oil Discovery in Thailand'
Source: Streetwise Reports  (9/27/19)
The drill results and next steps are reviewed in a Mackie Research Capital Corp. report. More >


Toronto Convention Center Agrees to Beta Test Concealed Weapons Detection Solution
Source: Streetwise Reports  (9/27/19)
The developer of this system continues to sign collaboration agreements. More >


Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study
Source: Streetwise Reports  (9/27/19)
Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. More >


Mineral Exploration Company Provides Project Updates
Source: Streetwise Reports  (9/26/19)
At its latest-stage asset, the firm continues to advance the recognized potential for development of bulk-tonnage, polymetallic deposits. More >


Maurice Jackson

Explorer Expands Footprint at the Golden Triangle Site
Source: Maurice Jackson for Streetwise Reports  (9/26/19)
In this interview with Maurice Jackson of Proven and Probable, Aben Resources' CEO explores the ramifications of recent analytical results from the company's flagship project. More >


Software Technology Small-Cap Inks US$10 Million Agreement to Provide Analytics and Security Technology in Mexico
Source: Streetwise Reports  (9/26/19)
The company's proprietary technology lowers costs and makes it scalable. More >


Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results
Source: Streetwise Reports  (9/26/19)
Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. More >


Osisko Gold Royalties Acquires Remaining Barkerville Shares
Source: Streetwise Reports  (9/25/19)
In a report, iA Securities explains the deal and makes a recommendation to the shareholders of the seller. More >


Uranium Explorer Completes Airborne Geophysics and Plans Drill Program for Athabasca Project
Source: Streetwise Reports  (9/25/19)
The Canadian company continues to unlock the discovery potential there. More >


Barrick-Newmont Goldcorp Joint Venture Leads to 'Cornucopia of Opportunities'
Source: Streetwise Reports  (9/25/19)
The synergies, potential and realized, that resulted from combining these two companies' Nevada assets are discussed in a BMO Capital Markets report. More >


Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials
Source: Streetwise Reports  (9/25/19)
The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hypercholesterolemia, which leads to high levels of LDL-C, and one for atherosclerotic cardiovascular disease. More >


Showing Results: 8101 to 8125 of 25391 Prev Next

Notable Quotes

"WEX remains an overweight position for me."
– Jeff Clark, TheGoldAdvisor.com
"IRV closed a fully subscribed financing, participated in by Crescat."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"PPTA was awarded up to $6.9M in 'defense funding.'"
– Jay Taylor, Gold, Energy & Tech Stocks

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"We should have a lot of news from DRY for the next few months."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"We value DC's Richmond Hill project at $2.531B."
– Peter Bell, Canaccord Genuity